10.03BMarket Cap
20.33P/E TTM
Dr Reddy's Laboratories Ltd
Key Figures
11.800Open
11.860High
3.01MVolume
20.33P/E TTM
25.97P/E Dynamic
0.091Dividend TTM
0.36%Turnover Ratio
11.830Prev. Close
11.720Low
16.94MTurnover
14.75P/E Static
2.45P/B
0.76%Div Yield TTM
8.03%ROA
16.17052wk High
0.98Volume Ratio
668.95MNet Profit
832.69MShares
0.5828EPS TTM
0.27Beta
12.23%ROE
12.18552wk Low
1.18%Amplitude
46.52%Gross Margin
10.03BMarket Cap
-15.69Reward/Risk
1.13%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Dr Reddy's Laboratories Ltd's fundamentals are relatively stable, and its growth potential is significant.Its valuation is considered fairly valued, ranking 82 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 13.56.In the medium term, the stock price is expected to trend down.The company has shown very weak stock market performance over the past month, in line with its fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Dr Reddy's Laboratories Ltd's Score
Support & Resistance

Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Dr Reddy's Laboratories Ltd Highlights
StrengthsRisks
Dr Reddy's Laboratories Ltd News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Dr Reddy's Laboratories Ltd
RDY
4
Indicators
Financial Indicators
EPS

Relevant data have not been disclosed by the company yet.
Total revenue

Relevant data have not been disclosed by the company yet.
Dr Reddy's Laboratories Ltd Info
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Ticker SymbolRDY
CompanyDr Reddy's Laboratories Ltd
CEOAghanian (Patrick)
Websitehttps://www.drreddys.com/
Shareholders
FAQs
What is the current price of Dr Reddy's Laboratories Ltd (RDY)?
The current price of Dr Reddy's Laboratories Ltd (RDY) is 11.85.
What is the symbol of Dr Reddy's Laboratories Ltd?
The ticker symbol of Dr Reddy's Laboratories Ltd is RDY.
What is the 52-week high of Dr Reddy's Laboratories Ltd?
The 52-week high of Dr Reddy's Laboratories Ltd is 16.17.
What is the 52-week low of Dr Reddy's Laboratories Ltd?
The 52-week low of Dr Reddy's Laboratories Ltd is 12.19.
What is the market capitalization of Dr Reddy's Laboratories Ltd?
The market capitalization of Dr Reddy's Laboratories Ltd is 9.87B.
Is Dr Reddy's Laboratories Ltd (RDY) currently rated as Buy, Hold, or Sell?
According to analysts, Dr Reddy's Laboratories Ltd (RDY) has an overall rating of signal_hold, with a price target of 13.56.
What is the Earnings Per Share (EPS TTM) of Dr Reddy's Laboratories Ltd (RDY)?
The Earnings Per Share (EPS TTM) of Dr Reddy's Laboratories Ltd (RDY) is 0.58.